# Tablet Scoring:Nomenclature, Labeling, and Data for Evaluation - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/tablet-scoringnomenclature-labeling-and-data-for-evaluation/d4b6bb69-1a24-4ebd-be2e-a80b08473b39

> FDA guidance document: Tablet Scoring:Nomenclature, Labeling, and Data for Evaluation. Issue date: March 13, 2013. Get complete insights and analysis.

---

## Details

- Title: Tablet Scoring:Nomenclature, Labeling, and Data for Evaluation
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2013-03-13
- Last Changed: 2020-05-05
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2011-D-0595">FDA-2011-D-0595</a>

## Related Documents

- [Residual Drug in Transdermal and Related Drug Delivery Systems:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/residual-drug-in-transdermal-and-related-drug-delivery-systems-guidance-for-industry/54698fcf-db58-4dd4-ac3a-81992e898cae)
- [ANDAs: Stability Testing of Drug Substances and Products, Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/andas-stability-testing-of-drug-substances-and-products-questions-and-answers/4506feda-4fad-4c68-a272-c1ce936ba67d)
- [ANDAs: Stability Testing of Drug Substances and Products](https://www.globalkeysolutions.net/guidances/guidance-document/andas-stability-testing-of-drug-substances-and-products/c3403aba-7f4f-4aa1-9f7b-94ae55a3486f)